DUBLIN?(BUSINESS WIRE)?Research and Markets (http://www.researchandmarkets.com/research/4ddfa0/the_outlook_for_ph)
has announced the addition of the The
Outlook for Pharmaceuticals in Latin America report to their
offering.
The
Outlook for Pharmaceuticals in Latin America
The region needs to increase drug access, in spite of intensifying
cost-containment measures. Therefore, attractive opportunities for
(bio)pharmaceutical producers exist in Latin America. Brazil has the
largest pharmaceutical market. Strong economic performance will fuel
pharmacy sales growth in the forecast period. Mexico is the second
leading market. Recent regulatory developments will create further
market opportunities in the country, particularly for generic producers
in both the private and public sectors. In Argentina, the pharmaceutical
industry is expected to perform well in the coming years, with strong
growth in production, sales, exports and employment. Pharmaceutical
companies, however, are encouraged to act in smaller Latin American
markets to maximise their full regional sales potential.
Generics consumption in Latin America is low, with the exception of
Brazil which has a dynamic bioequivalent generic sector. In the last two
years, foreign producers have penetrated what, until then, had been
considered a tough sector due to local protectionism and low prices.
These Reports Analyse the Issues:
The
Outlook for Pharmaceuticals in Latin America is a unique collection
of management reports from Espicom Business Intelligence. Each report
provides individual and highly-detailed analysis of each market, looking
at the key regulatory, political, economic and corporate developments in
the wider context of market structure, service and access. The reports
are available individually, or as a discounted collection, and prices
include 4 completely updated reports sent quarterly, together with a
comprehensive statistical appendix. There are over 60 markets covered in
the worldwide series.
Key Topics Covered:
MARKET OUTLOOK
- Current market size
- Unique 5-Year market projections to 2012
- Market outlook
- Comment amp; rating, covering 8 key areas such as use of generic drugs,
intellectual property, pricing and the health systems - Market structure
- Statistical data on imports and exports
- Market developments, covering recent and impending developments with
respect to key issues such as regulation, health facilities, funding
and government policy - Key national data projections
BACKGROUND DATA Population data, including growth trends and age
structure Demographic indicators detailing principal causes of death and
morbidity
HEALTHCARE SYSTEM
- Organisation amp; administration
- Health expenditure
- Hospital services
- Outpatient care
- Medical personnel
ACCESSING THE PHARMA MARKET
- Regulatory environment
- Distribution and trade fair information
- Domestic production
- Company information
CONTACT DETAILS
- For healthcare organisations and trade associations
For more information visit http://www.researchandmarkets.com/research/4ddfa0/the_outlook_for_ph
Source: Espicom Business Intelligence Ltd
Tags: Pharmaceutical
Source: http://www.transparency-az.org/?p=2717
cl p cl p andy rooney andy rooney groupon ipo groupon ipo breeders cup 2011
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.